
Avlar BioVentures was a specialist biotechnology venture capital firm based in Cambridge, UK, focused on early-stage and seed investments in bioscience companies. The firm managed multiple funds including Avlar BioVentures Fund II (£43 million) and the First Cambridge Gateway Fund (£35 million), and invested in 18 companies across a range of bioscience sub-sectors. It is now listed as out of business.